Observational study designs for comparative effectiveness research: an alternative approach to close evidence gaps in head-and-neck cancer.
暂无分享,去创建一个
Scott D Ramsey | Upendra Parvathaneni | S. Ramsey | U. Parvathaneni | Bernardo H L Goulart | B. Goulart
[1] S. Tunis,et al. Does comparative-effectiveness research threaten personalized medicine? , 2009, The New England journal of medicine.
[2] P. Warde,et al. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).
[3] J. Sham,et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.
[4] M. Maguire,et al. Identifying and eliminating the roadblocks to comparative-effectiveness research. , 2010, The New England journal of medicine.
[5] C. Pashos,et al. Economic burden of head and neck cancer , 2004, The European Journal of Health Economics, formerly: HEPAC.
[6] D. Fried,et al. Costs of Care in a Matched Pair Comparison of Intensity-modulated Radiation Therapy (IMRT) Versus Conventional Radiation Therapy (CRT) for the Treatment of Head and Neck Cancer , 2014, American journal of clinical oncology.
[7] M. Weinstein,et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.
[8] G. Lewith,et al. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions , 2006 .
[9] S. Porceddu,et al. Does fluorodeoxyglucose PET add to the management of the neck following curative radiotherapy in head and neck cancer compared with computed tomography? , 2013, Expert review of anticancer therapy.
[10] E. Vogtmann,et al. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid , 2012, Head & neck oncology.
[11] Nicholas F. Marko,et al. The role of observational investigations in comparative effectiveness research. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] G. de Lissovoy,et al. Can managed care organizations partner with manufacturers for comparative effectiveness research? , 2008, The American journal of managed care.
[13] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[14] D. Ronis,et al. The effect of neck dissection on quality of life after chemoradiation , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[15] A. Garden,et al. Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER–Medicare analysis , 2013, Head & neck.
[16] T. Lancaster,et al. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies , 2004, Statistical methods in medical research.
[17] J. Concato,et al. Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.
[18] Deborah Schrag,et al. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.
[19] Kenneth J. Smith,et al. A cost‐effectiveness analysis of positron emission tomography‐computed tomography surveillance versus up‐front neck dissection for management of the neck for N2 disease after chemoradiotherapy , 2012, The Laryngoscope.
[20] L. Collette,et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.
[21] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[22] R. D'Agostino. Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .
[23] S. Leung,et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Jan P Vandenbroucke,et al. When are observational studies as credible as randomised trials? , 2004, The Lancet.
[25] V. Mehta,et al. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.
[26] M. Shrime,et al. Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival? , 2012, Archives of otolaryngology--head & neck surgery.
[27] C. Perez,et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] Srinivasan Vijayakumar,et al. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. , 2011, International journal of radiation oncology, biology, physics.
[29] Clarence Balden Randall,et al. Report to the President and the Congress , 1954 .
[30] Sasa Mutic,et al. Developing a national radiation oncology registry: From acorns to oaks. , 2012, Practical radiation oncology.
[31] T. Koepsell,et al. Epidemiologic Methods: Studying the Occurrence of Illness , 2003 .
[32] A. Raben,et al. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. , 2009, International journal of radiation oncology, biology, physics.
[33] W. Hong,et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.
[34] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[35] Avraham Eisbruch,et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.
[36] D. Winchester,et al. National cancer data base. A clinical assessment of patients with cancer , 1992, Cancer.
[37] R. Weber,et al. Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival , 2006, The Laryngoscope.
[38] G. Lyman,et al. Comparative effectiveness research in oncology: an overview. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] J. Albert,et al. Quality indicators in radiation oncology. , 2013, International journal of radiation oncology, biology, physics.
[40] Ruth Etzioni,et al. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[42] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[43] Amy Y. Chen,et al. Longitudinal oncology registry of head and neck carcinoma (LORHAN) , 2011, Cancer.
[44] R. Schilsky,et al. Randomized controlled trials and comparative effectiveness research. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] R. Weber,et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.
[46] R. Tishler,et al. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[47] J. Turner,et al. Incidence and survival in patients with sinonasal cancer: A historical analysis of population‐based data , 2012, Head & neck.
[48] J. Heckman,et al. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. , 2007, Health economics.
[49] Wei Xu,et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] Alvin I Mushlin,et al. Health care reform and the need for comparative-effectiveness research. , 2010, The New England journal of medicine.
[51] Beth A Virnig,et al. Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.
[52] K. Frick,et al. National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short‐term outcomes and cost of care , 2012, The Laryngoscope.
[53] Fei Liu,et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. , 2001, International journal of radiation oncology, biology, physics.
[54] G. Lanke,et al. Mo1143 Is Lymph Node Ratio (LNR) a Prognostic Marker in Patients With Colon Cancer? A Study in National Cancer Institute's Surveillance Epidemiology, and End Results (SEER) Database , 2013 .
[55] Amy Y. Chen,et al. Improved survival is associated with treatment at high‐volume teaching facilities for patients with advanced stage laryngeal cancer , 2010, Cancer.
[56] Esther Kim,et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] J. Debus,et al. Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT , 2011, BMC Cancer.
[58] N. Lee,et al. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[59] Angela Mariotto,et al. Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[60] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] J. Albert,et al. Quality assessment in oncology. , 2012, International journal of radiation oncology, biology, physics.
[62] S. Kannan,et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] D. Hershman,et al. Comparative effectiveness research in oncology methodology: observational data. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] L. Dawson,et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.